Find & Book an Oncologist near you

Dr Stephen Stylian is a Clinical Haematologist and Medical Oncologist with over two decades of experience. He received his Bachelor of Medicine, Bachelor of Surgery from the University of New South Wales in 1995 and holds a Fellowship of the Royal Australasian College of Physicians. After completing his basic physician training at the Gold Coast Hospital, Dr Stylian pursued further training in Haematology and Oncology in various states across Australia. He currently runs a well-established practice serving the Gold Coast and Northern N.S.W., attending to patients from various regions throughout the country. Dr Stylian's main areas of focus include Haematology, Oncology, Stem Cell Transplantation, Apheresis, and Palliative Care. He has a special interest in managing complex Haemato-Oncologic problems and providing multiple lines of life-prolonging therapies to cancer patients. To further his commitment to excellence in care, Dr Stylian has established a cancer center of excellence at Pindara Hospital on the Gold Coast, where he offers cutting-edge treatments and manages complex disorders. Dr Stylian is an accredited practitioner at several prestigious hospitals, including Allamanda, Pindara, John Flynn, and Greenslopes Hospitals. His extensive experience and unwavering commitment to providing exceptional care have earned him a high level of respect in his field, and he is trusted by numerous patients across Australia. Please note that while this bio provides a general overview of Dr Stylian's profile, it may not include every detail of his professional background and accomplishments.

Associate Professor Andrew Strickland is a medical oncologist and clinical researcher specializing in gastrointestinal cancer. Based at Holmesglen Private Hospital in Noble Park, Melbourne, Victoria, Australia, he is highly regarded in his field. With a primary focus on gastrointestinal (GI) cancer, Andrew specializes in the diagnosis and management of various GI tumors, including colorectal, gastroesophageal, pancreatic, neuroendocrine, and other GI cancers. He is recognized as the tumour stream lead in gastrointestinal cancer at Monash, actively participating in multidisciplinary team meetings. Born and raised in Melbourne, Andrew further honed his skills in medical oncology by pursuing a fellowship at Guy's Hospital in London. During this time, he specialized in upper gastrointestinal cancer, gaining extensive experience in the field. Andrew is a respected member of several prominent medical societies and associations. He actively contributes to the Australian Gastrointestinal Trials Group (AGITG), the Medical Oncology Group of Australia (MOGA), and the American Society of Clinical Oncology (ASCO). He has published over 70 peer-reviewed articles and reviews, making significant contributions to the field. Additionally, he serves as a reviewer for esteemed journals. Beyond his professional achievements, Andrew is known for his compassionate approach to patient care and exceptional communication skills. He is dedicated to improving his patients' quality of life by providing comprehensive and compassionate care throughout their treatment journeys.

Dr Keith Horwood is a respected and accomplished Medical Oncologist specializing in thoracic, women's, and upper gastrointestinal oncology. He practices at Greenslopes Private Hospital and Icon Cancer Centre Southport in Southport, Australia. Dr Horwood earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Queensland in 1989. Following his medical education, he completed his specialist training in medical oncology in 1997. Seeking to enhance his skills, he pursued a clinical fellowship in the United States and subsequently returned to Brisbane as a specialist at the Royal Brisbane Hospital. Since 2001, Dr Horwood has been dedicated to providing exceptional patient care in private practice. In 2014, he joined the team at Icon Cancer Centre, where he continues to deliver outstanding care as a Medical Oncologist. Dr Horwood's accomplishments have earned him the distinction of being a Fellow of the Royal Australasian College of Physicians (FRACP). His fellowship is a testament to his expertise and unwavering commitment to maintaining the highest standards of medical practice. He also actively participates in various advisory boards and clinical trial group committees, including the Australasian Lung Cancer Trials Group (ALTG) and the American Society of Clinical Oncology (ASCO). Dr Horwood's primary focus is on breast cancer, gastrointestinal cancer, lung cancer, and ovarian cancer. With his extensive experience and refined skills in these areas, he provides comprehensive and personalized care, ensuring that his patients receive the best treatment options tailored to their individual needs. Passionate about advancing the field of oncology, Dr Horwood actively engages in clinical research. His involvement in advisory boards and clinical trial group committees allows him to contribute to the latest developments and advancements in cancer treatment. Compassionate and understanding, Dr Horwood recognizes the impact that a cancer diagnosis can have on patients and their families. He is dedicated to providing unwavering support throughout their cancer journey, offering not only medical expertise but also empathy and kindness. Dr Keith Horwood, an esteemed Medical Oncologist, continues to make significant contributions to the field of oncology through his clinical research and unwavering commitment to patient care. Patients under his care can trust that they are in the hands of a compassionate professional who will go above and beyond to provide the highest standard of comprehensive and personalized treatment.

A/Prof Paul Vasey is an esteemed medical oncologist specializing in the treatment of various types of cancer. Currently practicing in Auchenflower, Brisbane, Queensland, Australia, he is associated with St Andrews Ipswich Private Hospital. Throughout his career, Dr Vasey has developed significant expertise in the field of oncology, with a special focus on genitourinary cancer, gynecological cancer, lung cancer, and ovarian cancer. His medical journey commenced in Newcastle, UK, where he obtained his MBChB degree. He then pursued research, serving as a Cancer Research UK Clinical Research fellow and Clinical Lecturer in the Department of Oncology at the University of Glasgow. During his time in Glasgow, he earned an MSc in Clinical Pharmacology and an MD for his thesis on in vitro studies of cisplatin-resistant human ovarian carcinoma cells. He held several positions, including Cancer Research UK Senior Lecturer in Medical Oncology and Honorary Consultant in Medical Oncology at the Beatson Oncology Centre. In 2004, Dr Vasey relocated to Australia, where he became a Fellow of the Royal Australasian College of Physicians. He assumed positions of Associate Professor with the University of Queensland and Honorary Associate with the University of Sydney. Dr Vasey's research interests predominantly encompass women's and genitourinary cancers. He has held significant roles within the medical community, including chairmanship of the Scottish Gynaecologic Cancer Trials Group. Additionally, he has served as an executive board member on various UK national genitourinary and gynaecologic cancer trials national steering groups. Another notable achievement is his role as the inaugural author of the European Society for Medical Oncology (ESMO) guidelines for the treatment of ovarian cancer. Dr Vasey's extensive research efforts have resulted in the publication of over 200 books, peer-reviewed journals, and conference proceedings. Presently, Dr Vasey practices with the ICON group, where he serves as a visiting senior medical oncologist at the Wesley Hospital in Brisbane. He also regularly consults at St Andrew's Private Hospital in Ipswich. Known for his compassionate and supportive approach to patient care, Dr Vasey tirelessly works towards advancing cancer treatments and providing his patients with cutting-edge, evidence-based therapies.

A/Prof Gavin Marx is an esteemed Oncologist based in Frenchs Forest, Sydney, New South Wales, Australia. With a BSc (Med) and MBBS (Hons) under his belt, as well as being a Fellow of the Royal Australasian College of Physicians (FRACP), A/Prof Marx has acquired a wealth of knowledge and experience in the field of oncology. A/Prof Marx's primary areas of expertise lie in the treatment of hormone refractory prostate cancer, as well as breast and colon cancer. His extensive experience and specialised knowledge in these areas make him a respected authority in the field. A/Prof Marx's passion for oncology and providing the best possible care for his patients are evident in his practice. He is known for his meticulous approach to treatment and patient-centered care. A/Prof Marx, a male practitioner, primarily communicates in English and has not listed any other languages spoken. Though no awards are currently listed, A/Prof Marx's contributions to the field of oncology are highly regarded, and his dedication to advancing the understanding and treatment of cancer is widely respected. In summary, A/Prof Gavin Marx is a well qualified and dedicated oncologist, specialising in the treatment of hormone refractory prostate cancer, breast cancer, and colon cancer. With an extensive medical background, coupled with his commitment to ongoing education, A/Prof Marx is well-equipped to provide his patients with the highest level of care and expertise.

Dr Prasad Cooray is a dedicated and compassionate general oncologist who specialises in treating various types of cancer, including gastrointestinal, hepato-biliary, genitourinary, and lung cancers. He completed his MBBS (Hons) from Monash University in 1996 and received advanced training at Melbourne's Peter MacCallum Cancer Centre and The Austin and Alfred Hospitals. Dr Cooray actively participates in cancer clinical trials as a co-investigator and regularly attends multidisciplinary team meetings to ensure comprehensive and coordinated care for his patients. In 2014, he established Yarra Oncology to provide exceptional medical care and support to cancer patients, advocating for their well-being. Fluent in Sinhalese, Dr Cooray is able to cater to diverse communities and effectively communicate with patients who prefer their native language. He considers it a privilege to work as an oncologist, finding fulfillment in treating, educating, and empowering his patients during challenging times. With his extensive knowledge in oncology and his commitment to the physical and emotional well-being of his patients, Dr Cooray serves as a beacon of hope for those seeking medical intervention for cancer. His patient-centred approach, combined with his dedication to staying updated with the latest advancements in oncology, ensures that his patients receive exceptional care and support throughout their cancer journey.

A/Prof Tim Clay practices as a medical oncologist at Icon Cancer Centre Midland in Subiaco, Western Australia. He obtained his MBBS degree with honors from the University of Western Australia in 2004 and went on to become a Fellow of the Royal Australasian College of Physicians (FRACP) after completing his specialty training in oncology in 2012. A/Prof Clay holds a DMedSci degree from the University of Melbourne, with a focus on lung cancer pathology. A/Prof Clay's dedication extends to education and teaching. As an Adjunct Associate Professor at Edith Cowan University, he shares his knowledge and expertise with junior doctors, nurses, and allied health staff. He is known for his commitment to providing the highest quality of care to his patients and ensuring they have access to the latest treatment options. Please note that A/Prof Clay does not accept referrals for gynecological cancers, sarcoma, or central nervous system malignancies. Outside of his professional life, he enjoys spending time with his family and indulging in hobbies such as motor racing, soccer, and Australian music. With his extensive qualifications, clinical expertise, and commitment to advancing cancer care, A/Prof Tim Clay is a well-respected and sought-after medical oncologist in Western Australia.

Dr Jeremy Shapiro is an esteemed oncologist based in Malvern, Melbourne. Graduating from Monash University in 1989 with an MBBS qualification, Dr Shapiro went on to pursue further training and specialization in Australia. He gained invaluable experience at renowned healthcare institutions such as the Alfred Hospital, Monash Medical Centre, and Peter MacCallum Cancer Institute. In 1996, Dr Shapiro embarked on a research program at the National Cancer Institute in the United States, focusing on Gastro-Intestinal Cancer. This program spanned over three years and greatly contributed to his expertise in this field. Currently, Dr Shapiro holds multiple significant roles within the medical community. He serves as an Associate Professor in the Department of Medicine at Monash University, where he shares his knowledge and expertise with aspiring medical professionals. Additionally, Dr Shapiro is associated with Waverley Private Hospital, where he provides exceptional care to his patients. Dr Shapiro is highly regarded for his contributions to clinical research in Gastrointestinal cancer. He is an esteemed researcher and serves as a lead researcher at the Australian Gastrointestinal Tumour Group. In this capacity, he chairs two international trials that focus on refractory colorectal cancer. Additionally, he oversees various other gastro-intestinal cancer trials. One of Dr Shapiro's notable involvements is chairing EVIQ's (Evidence-based Oncology Protocols Committee). This initiative is aimed at enhancing the evaluation and management of holistic cancer care. Driven by his passion for enhancing patient care, Dr Shapiro actively participates in this Australian-based initiative. Dr Shapiro's dedication to the advancement of cancer research is exemplified by his extensive publications in peer-reviewed journals and abstracts. Over the years, he has published more than 80 papers, showcasing his commitment to educating fellow medical professionals through literature. With his extensive experience, deep knowledge in his field of specialty, and dedication to advancing cancer care, Dr Jeremy Shapiro is a well-respected oncologist who is committed to providing exceptional healthcare to his patients.

Dr Oliver Klein, an experienced oncologist, is dedicated to the treatment of various types of cancer. He is based in Frankston, Melbourne, Australia and is affiliated with Peninsula Private Hospital Vic. Dr Klein obtained his Doctor of Medicine degree in 2000 after completing his medical training in Germany. He continued his training in medical oncology and clinical hematology in Germany before relocating to Australia. Upon arriving in Australia, Dr Klein joined the renowned Ludwig Institute for Cancer Research at the Austin Hospital. There, he served as a postdoctoral and clinical research fellow, actively involved in melanoma and cancer immunotherapy research. Due to his dedication and contributions to the field, Dr Klein underwent further training in medical oncology at Westmead Hospital in Sydney. Dr Klein received Fellowship recognition from the Royal Australasian College of Physicians for his advanced training and expertise in medical oncology. He continues to actively participate in clinical trials and research projects in collaboration with the Ludwig Institute, Westmead Hospital, and the Melanoma Institute Australia. Dr Klein's research primarily focuses on innovative approaches to cancer treatment by harnessing the immune system's potential to combat cancer. His research findings have been extensively published in prestigious medical journals, further contributing to the advancement of cancer care. He is a member of the Medical Oncology Association of Australia and the American Association of Medical Oncology. Dr Klein is fluent in English and German. Dr Oliver Klein's commitment to oncology, extensive research experience, and ongoing involvement in clinical practice have earned him the respect and admiration of the medical community. He is a valued member of the field, striving to make a significant impact in the treatment and management of cancer.

Dr Warren Joubert is a Medical Oncologist with over 25 years of experience in the medical field. He earned his medical degree, MB BCH W'RAND, from the University of Witwatersrand, South Africa in 1995 and is a Fellow of the Royal Australasian College of Physicians (FRACP). Dr Joubert specialized in Medical Oncology at the Princess Alexandra Hospital in Brisbane, where he currently holds a senior staff specialist position. He is renowned for his expertise in gastro-intestinal cancer, uro-genital cancer, sarcoma oncology, and neuroendocrine tumors. He actively participates in clinical trials as a member of the Australasian Gastro-intestinal Trials Group, contributing to the advancement of treatment options for various types of cancer. Dr Joubert is dedicated to a patient-centered approach, providing personalized and evidence-based therapies. He takes a holistic approach to patient care, offering comprehensive support to both patients and their families throughout the treatment process. Dr Joubert's commitment to delivering exceptional care has earned him a well-respected reputation in the field of oncology. In addition to his role at the Princess Alexandra Hospital, Dr Joubert also operates a private practice at Greenslopes Hospital. With his extensive experience and dedication to patient care, he strives to make a positive impact on the lives of his patients.

Dr Marco Matos is an esteemed medical professional specializing in oncology, with his primary practice located in Southport, Gold Coast, Queensland, Australia. He is affiliated with two prestigious hospitals in the area, namely Gold Coast Private Hospital and Pindara Private Hospital. Dr Matos is fluent in both English and Spanish. Dr Matos has a primary professional interest in oncology, focusing on gastrointestinal, breast, gynecological, respiratory, and head and neck malignancies. He is known for his extensive experience in the field and dedication to providing exceptional care to his patients. Dr Matos consistently stays updated with the latest advancements in his field. In addition to his clinical practice, Dr Matos is actively involved in the training and education of advanced oncology trainees and undergraduate students from Griffiths and Bond Universities. He is an active member of renowned national and international organizations, including the American Society of Medical Oncology (ASCO), the European Society of Medical Oncology (ESMO), the Medical Oncology Group of Australia (MOGA), and the Australasian GastroIntestinal Trials Group (AGITG). Dr Matos has played a pivotal role in establishing the monthly Gold Coast Cooperative Oncology Group meetings, bringing together medical oncologists, radiation oncologists, surgeons, respiratory physicians, and pathologists. He has also participated in numerous clinical trials, making substantial contributions to patient care and treatment outcomes. As a principal investigator in trials such as LIGHT, RAINBOW, SIRFLOX, and FOXFIRE, Dr Matos has advanced our understanding of different cancer therapies. Outside of his professional life, Dr Matos enjoys gardening and sports, particularly football. He is a family-oriented person and is married with three children, Fiorella, Marco Isaac, and Fernando. Dr Marco Matos is an esteemed oncologist who is dedicated to delivering exceptional care to his patients and advancing the field of oncology through his clinical practice, research, and contributions to the medical community.

Dr Craig Carden is an oncologist based in Ballarat, Victoria, Australia. With a wealth of experience spanning over two decades, he specializes in the diagnosis and treatment of various types of cancer. His areas of focus include prostate, lung, and ovarian cancer. Dr Carden is dedicated to advancing the understanding and treatment of ovarian cancer through his research program which centers around a molecular pathway found in samples from ovarian cancer patients. Dr Carden's approach to patient care is underpinned by compassion. He is committed to delivering the highest standard of care and ensures that patients and their families receive clear and comprehensive communication throughout their cancer journey. At present, Dr Carden does not have any associated hospitals and information regarding any awards he may have received is unavailable. In addition to being fluent in English, Dr Carden is proficient in other languages. Unfortunately, details regarding his linguistic abilities are currently not known. Dr Craig Carden is a respected figure within the community, known for his expertise, dedication, and unwavering commitment to improving outcomes for cancer patients. His contributions to the field of oncology through research and compassionate care have earned him high regard from both patients and colleagues alike.

Dr Sanjay Mukhedkar is an experienced oncologist based in Murdoch, a suburb of Perth in Western Australia. With a primary practice in this area, he is dedicated to providing exceptional medical care to his patients. Dr Mukhedkar is a highly qualified professional, with extensive knowledge and expertise in the field of oncology. Dr Mukhedkar is fluent in multiple languages including Hindi, Marathi, Telugu, and Urdu. This linguistic versatility enables him to effectively communicate with patients from diverse cultural backgrounds, ensuring their comfort and understanding throughout the treatment process. Dr Mukhedkar has a special interest in lung cancer and cancers of the gastrointestinal tract. His focused expertise allows him to provide advanced and specialised care in these areas, ensuring his patients benefit from the latest advancements in the field. To further enhance his skills and knowledge, Dr Mukhedkar regularly attends conferences and workshops related to oncology. This commitment to staying up-to-date with the latest research and treatment options enables him to offer his patients the best possible care. Dr Mukhedkar is currently practicing in Murdoch, Perth, but does not have any specific affiliations with any hospitals at this time. In summary, Dr Sanjay Mukhedkar is an oncologist based in Murdoch, Perth, Western Australia. With expertise in lung cancer and gastrointestinal tract cancers, he offers specialised and effective care to his patients. Dr Mukhedkar's commitment to ongoing professional development ensures that his patients benefit from the most advanced treatment options available.

Dr Alireza (Ali) Fallah is a medical oncologist based in Melbourne, Australia. He practices medical oncology and internal medicine in several public and private hospitals in Melbourne, where he provides specialized care to cancer patients. Dr Fallah has a particular interest in gastrointestinal, lung, breast, and genitourinary cancers. With a dedication to advocating for extensive cancer screening, Dr Fallah aims to detect cancer early and increase the chances of successful treatment. He stays up to date with the latest advances in oncology and has extensive experience with immunotherapy in treating various cancers. Dr Fallah takes a multidisciplinary approach in treating his patients. He collaborates closely with other specialists and a team of healthcare professionals to ensure the best possible care. This team includes dieticians, psycho-oncologists, palliative care and chemotherapy nurses, and allied health workers. Dr Fallah believes in providing high-quality and compassionate care, empowering patients and their families through effective communication and education. In addition to his expertise in medical oncology, Dr Fallah has a focus on internal medicine. He specializes in perioperative medicine, chronic multisystem disease, pain management, and cancer screening. Dr Fallah has a background in research and has published numerous scientific papers and presentations in various scientific meetings. Dr Fallah is a fellow of the Royal Australasian College of Physicians and is a member of several professional organizations. These include the Internal Medicine Society of Australia, the Medical Oncology Group of Australia, the American Society of Clinical Oncology, and the European Society of Medical Oncology. He is also a senior adjunct lecturer at Monash University, where he shares his knowledge and experience with future healthcare professionals. Dr Fallah obtained his medical degree (M.D.) in Australia and completed his specialist training in medical oncology (FRACP). He is fluent in English and Farsi, allowing him to effectively communicate with patients from diverse backgrounds.

Dr Nick Pavlakis is a medical oncologist specializing in the diagnosis and treatment of solid tumors. Practicing primarily in Frenchs Forest, Sydney, New South Wales, Australia, Dr Pavlakis is affiliated with the North Shore Private Hospital, where he holds a VMO position. With a medical degree from the University of New South Wales in 1991, Dr Pavlakis completed his general medical training and advanced training in Medical Oncology at the Royal North Shore Hospital. In 1997, he earned his FRACP qualification. Dr Pavlakis also pursued further education, obtaining a PhD in new cancer drug development and a Master's in Clinical Epidemiology from the University of Sydney. Dr Pavlakis has been an esteemed member of the Department of Medical Oncology at the Royal North Shore Hospital since 2001. Currently, he serves as the Head of Department and Head of the Clinical Trials Unit. He is also involved with the Northern Cancer Institute as a private oncologist. Dr Pavlakis's broad range of experience has led to his involvement with various organizations and advisory boards. He has been part of the Medical Oncology Group of Australia (MOGA), the Private Cancer Physicians Group of Australia (PCPA), and the Australian Lung Cancer Trials Group. Additionally, he has served on advisory boards for colorectal and lung cancers, as well as new cancer drugs. Dr Pavlakis is recognized for his expertise in anti-angiogenesis drugs and his commitment to advancing the development of new cancer therapies. As an academic medical oncologist, Dr Pavlakis has made significant contributions to the field. He has published numerous journal manuscripts and actively collaborates with institutions such as RNSH, NCI (University of Sydney), MOGA, PCPA, and RACP in research and teaching endeavors. Dr Pavlakis focuses his research and clinical practice on lung cancers, mesothelioma, colorectal cancers, gastrointestinal cancers, and genitourinary cancers. In addition to his medical expertise, Dr Pavlakis is fluent in Greek. He is committed to providing personalized, compassionate care to his patients, ensuring that they receive the highest standard of treatment.

Dr Ramin Behzadigohar is a respected oncologist based in Frankston, Melbourne, Australia. He obtained his MBBS degree from Tehran University of Medical Sciences in Iran in 2005 and subsequently moved to Australia, where he obtained his AMC Certificate from the Australian Medical Council in 2010. Dr Behzadigohar's passion for oncology led him to pursue further training and complete his fellowship in medical oncology through the Victorian Medical Oncology Training Group. During this time, he gained invaluable experience at renowned teaching hospitals such as St Vincent's Hospital, Royal Melbourne Hospital, and Monash Medical Centre. As a testament to his expertise and dedication, Dr Behzadigohar became a Fellow of the Royal Australasian College of Physicians. He is an active member of the Medical Oncology Group of Australia and the American Society of Clinical Oncology, demonstrating his commitment to staying up-to-date with the latest advancements in the field. Dr Behzadigohar has a strong interest in research and has actively contributed to various clinical trials, including phase 1, 2, and 3 studies. As a Clinical Research Fellow at the Monash Health Translation Precinct, he focuses on advancing oncology treatments to improve patient outcomes. Currently working as a consultant Medical Oncologist with PASO Medical, Dr Behzadigohar specializes in gastrointestinal, breast, and genitourinary cancers. His extensive expertise and compassionate approach to patient care have made him highly sought-after. Dr Behzadigohar's qualifications and professional affiliations, combined with his dedication to patient-centered care, make him a respected and valuable asset to the field of medicine. He is committed to making significant contributions to the oncology community by continually improving patient outcomes through exceptional work and research.

Dr Jeremy Long is a Haemato-Oncologist specializing in lung cancer, urological malignancies, lymphoma, supportive care, and cancer survivorship. He obtained his Bachelor of Medicine, Bachelor of Surgery from the University of Witwatersrand in South Africa in 1985 and became a Fellow of the Royal Australasian College of Physicians in 1998. Prior to his specialization in Haemato-Oncology, Dr Long served as a Lieutenant in the Military for two years. Since obtaining his specialization in 1994, he has worked as a Specialist in South Africa and migrated to New Zealand in 1996, where he worked at Auckland Hospital and Waikato Hospital. It was during this time that he received his FRACP in Medical Oncology in 1999. From 2002 to 2008, Dr Long served as the Director of the Regional Cancer Centre for the Waikato District Health Board. In 2008, Dr Long relocated to Nambour, Queensland, Australia and took on the role of Director of Cancer Care Services for the Sunshine Coast Hospital and Health Service in 2010, a position he held until 2020. During his tenure, he provided high-quality care and expertise to patients, establishing himself as a trusted figure in the field of Haemato-Oncology. Dr Long is a firm believer in the power of multi-disciplinary teamwork and actively participates in various MDT groups at Sunshine Coast University Hospital (SCUH), Buderim Private, and Sunshine Coast University Private Hospital (SCUPH). These groups focus on areas such as lung, urology, breast, and general MDT, allowing Dr Long to collaborate with other medical professionals to provide comprehensive care for his patients. With a commitment to staying up to date with the latest advancements in his field, Dr Long is a member of several professional organizations and research groups, including the Australian Gastrointestinal Trials Group (AGTIG), Australian Lung Trials Group (ALTG), Australia and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), American Society of Clinical Oncology (ASCO), Breast Cancer Trials (BCT), Clinical Oncology Society of Australia (COSA), and the Medical Oncology Group of Australia (MOGA). Dr Long's dedication to providing exceptional care and his passion for oncology have earned him a reputation as a highly-regarded specialist. Whether working as part of a multi-disciplinary team or individually with patients, he consistently strives to ensure the highest level of care while contributing to the advancement of oncology research and treatment.

Dr Muhammad Alamgeer is an experienced oncologist based in Mornington, Melbourne, Victoria, Australia. He specialises in the treatment of various types of cancers and is part of the distinguished Oncology Team at Healthscope. Dr Alamgeer practices at Holmesglen Private Hospital, where he offers expert advice and treatment to individuals seeking his services. Known for his compassionate nature, Dr Alamgeer ensures that his patients receive not only the best medical care but also emotional support throughout their journey. He takes the time to listen to his patients, understand their concerns, and discuss treatment options in a comprehensive and understandable manner. Dr Alamgeer's dedication to his patients' well-being is evident in his extensive involvement in clinical trials. He has a special interest in clinical trials as a means of advancing treatment options and improving patient outcomes. In addition to his clinical practice, Dr Alamgeer is an accomplished researcher. He has published numerous articles in well-regarded medical journals, contributing to the advancement of oncology knowledge and understanding. Recognized for his contributions to the field of oncology, Dr Alamgeer has received several grants and awards, including the Slater and Gordon Health Projects and Research Grant, the Monash Senior Medical Staff Association Emerging Investigator Research Award, the 'Rising Star Researcher of 2015' awarded by MHTP, and the Monash Comprehensive Cancer Care research grant. Dr Alamgeer's expertise, dedication, and compassionate approach make him an invaluable member of the Healthscope Oncology Team. With his commitment to providing exceptional care and advice, he strives to achieve the best outcomes for his patients.

Dr Lionel Lim is a medical oncologist based in Ringwood East, Melbourne, Victoria, Australia. With over two decades of experience in the field, Dr Lim specializes in the treatment of various types of cancers. Dr Lim earned his medical degree, MBBS, from Monash University in 1996. After completing his Physician training in 2002, he pursued advanced medical oncology training at Royal Melbourne and St Vincent’s Hospitals, enhancing his expertise in the field. Dr Lim served as a research fellow at the Peter MacCallum Cancer Centre in 2004, contributing to several research projects and publishing numerous research papers, particularly in the realm of colorectal and gastric cancers. His dedication to advancing the understanding and treatment of cancers is evident in his commitment to ongoing education and research. Completing a postgraduate research degree (MD) at the Ludwig Institute of Cancer Research from 2005 to 2009, Dr Lim focused on developing a serum-based biomarker for the detection of colorectal cancer. This exemplifies his dedication to improving diagnostic techniques and patient outcomes. Dr Lim currently runs a successful private practice at Ringwood Private Hospital, where he specializes in treating patients with various types of tumors, particularly gastrointestinal cancers such as those affecting the colon, rectum, pancreas, gastric, and esophagus. He also has expertise in managing lung and prostate cancers. In addition to his private practice, Dr Lim plays a vital role in the oncology unit at Eastern Health's Maroondah Hospital, contributing to a multidisciplinary approach to cancer treatment. He actively participates in cancer multidisciplinary meetings held at Knox and Ringwood Private Hospitals, collaborating with other healthcare professionals to develop comprehensive treatment plans. Fluency in Cantonese, Hokkien, Malay, Mandarin, and English allows Dr Lim to effectively communicate with patients from diverse backgrounds, fostering trust and delivering personalized care. His dedication and expertise in medical oncology make him a valuable member of the team at Ringwood Private Hospital, ensuring high-quality, compassionate care for patients. Please note that Dr Lionel Lim has not received any awards at this time.

Dr Rajanikar Tota is a medical oncologist at the Icon Cancer Centre in Rockingham, Greenfields, Western Australia. Dr Tota graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) in 2000 and obtained his AMC Certificate in 2012. He also completed a Fellowship of the Royal Australasian College of Physicians in 2012. Currently, Dr Tota is pursuing a Masters in Clinical Epidemiology from the University of Sydney to expand his knowledge and skills. Dr Tota believes in creating a comfortable and safe environment for his patients, encouraging open communication and ensuring they understand their diagnosis and treatment options. With a patient-centered approach, he empowers patients and their families to make informed decisions regarding their cancer management. With a special interest in clinical research, Dr Tota actively participates in research studies and incorporates the latest advancements in cancer treatment into his practice. He has extensive experience in providing patients with access to cutting-edge treatments, such as immunotherapy, across various types of cancer. Dr Tota ensures that his patients benefit from the most advanced and effective therapies available. Dr Tota's clinical experience spans a wide range of solid tumor malignancies. However, he has developed a particular interest in colorectal cancer, gastroesophageal cancer, lung cancer, melanoma, and genitourinary and urological cancers. His expertise in these areas allows him to provide specialized and comprehensive care, tailoring treatment plans to meet individual needs. In addition to his medical expertise, Dr Tota is fluent in Hindi and English, enabling him to effectively communicate with patients from diverse backgrounds and provide culturally sensitive care. As a dedicated medical professional, Dr Rajanikar Tota is committed to improving the lives of his patients through holistic cancer care, clinical research, and access to the latest treatment options. His exceptional skills, compassionate approach, and unwavering commitment to his patients make him a valued member of the medical community.

Dr Allan Zimet is a highly regarded Oncologist based in Sunbury, Victoria, Australia. With a primary practicing suburb of Sunbury and affiliation with John Fawkner Private Hospital, Dr Zimet has established himself as a respected figure within the medical community. Dr Zimet completed his Bachelor of Medicine and Bachelor of Surgery from the University of Melbourne in 1976, followed by a postgraduate program at the Alfred Hospital and Peter MacCallum Cancer Institute. To further enhance his expertise in oncology, he spent two years as a Clinical Research Fellow at Mt Sinai Hospital in New York. Dr Zimet specializes in the treatment of gastrointestinal cancers such as colon, stomach, esophageal, and pancreatic cancers, as well as lung cancer, lymphoma, myeloma, breast cancer, and central nervous tumors. His extensive training and experience enable him to provide exceptional care and treatment for patients with these complex conditions. Known for his patient-centric approach, Dr Zimet focuses not only on the treatment of cancer but also on improving the quality of life and extending the lives of his patients. He is dedicated to delivering compassionate, personalized care and stays updated with the latest advancements in oncology to ensure the best possible outcomes. Fluent in multiple languages, including English, French, Hebrew, and Italian, Dr Zimet effectively communicates with a diverse range of patients. He is highly skilled at explaining diagnoses, treatment options, and the implications of various conditions, ensuring that patients have a clear understanding of their healthcare journey. Dr Allan Zimet's unwavering commitment to excellence has earned him a stellar reputation within the field of oncology. His vast knowledge, extensive training, and dedication to his patients make him a trusted figure in the medical community. Through his tireless efforts, Dr Zimet continues to positively impact the lives of many and significantly contribute to the local medical landscape.

Dr Zhen Siow is a medical oncologist specializing in the treatment of cancer. Based in Box Hill, Melbourne, Dr Zhen serves the community of Victoria, Australia and is affiliated with Ringwood Private Hospital. He focuses on breast cancer and lung cancer, with a dedication to staying up-to-date on the latest advancements in oncology. Dr Zhen completed his training at renowned hospitals in Victoria and further enhanced his expertise through a translational research fellowship at the Walter and Eliza Hall Institute of Medical Research. During this fellowship, he conducted in-depth research on innovative therapeutic agents for breast cancer treatment. His main objective is to offer evidence-based treatments that provide his patients with the best possible outcomes. Dr Zhen believes in spending quality time with his patients, fostering open and honest discussions, and guiding them through their treatment choices. In addition to English, Dr Zhen is proficient in Chinese (Mandarin) and Malay, allowing him to effectively understand and communicate with patients from diverse linguistic backgrounds. Dr Zhen remains dedicated to ongoing innovation and staying at the forefront of medical advancements. His commitment to his patients' well-being drives him to continually seek out the latest treatment options to provide the best possible care. In summary, Dr Zhen Siow is a qualified and compassionate medical oncologist with a specialization in breast and lung cancer. Through his extensive education, training, and research experience, he offers evidence-based treatments and personalized care to his patients, ensuring the best possible outcomes. Dr Zhen's approachable demeanor and excellent communication skills make him a trusted healthcare provider who is committed to guiding his patients through their treatment journey.

Dr Andre Van der Westhuizen is a Medical Oncologist and Medical Geneticist with over 15 years of clinical experience. He conducts research at the Department of Medical Oncology at Calvary Mater Newcastle in Australia and serves as a full-time Medical Oncologist at the Calvary Mater Hospital. He also offers consultations at his private practice at Lake Macquarie Private Hospital. Dr Van der Westhuizen specializes in immuno-oncology clinical and pre-clinical research, with a particular focus on melanoma, immunotherapy, gastrointestinal cancer, breast cancer, lung cancer, and cancer genetics. He has served as the principal investigator for over 20 medical oncology clinical trials, including investigator-initiated studies and immunotherapy-oncology trials such as the KEYNOTE-001 trial. This trial evaluated the efficacy of anti-PD1 therapy in metastatic melanoma and lung cancer. He is an active member of the Hunter Medical Research Institute and has been part of the HMRI/University of Newcastle DNA repair group since 2013, focusing on translational research. Dr Van der Westhuizen has initiated his own investigator-led clinical trials and has a particular interest in studying the response/exposure relationship of anti-PD1 antibodies, including anti-PD1 trough levels and blood profile markers in patients receiving immunotherapy. In addition to his expertise in medical oncology, Dr Van der Westhuizen is also a qualified medical geneticist, holding a Master's degree in Genetic Counselling. He has led clinical trials focusing on genetic testing for inherited mutations and genetic counseling in cancer management. Dr Van der Westhuizen's contributions to the field extend beyond his clinical practice and research. He serves as an Advanced Trainee Supervisor at Calvary Mater Hospital and as a Conjoint Senior Lecturer at the University of Newcastle, where he mentors and shares his knowledge with aspiring medical professionals. Throughout his career, Dr Van der Westhuizen has published extensively in peer-reviewed journals and has presented his work at distinguished conferences worldwide. His academic achievements, publications, and presentations can be found on his ORCID profile. With his vast experience, Dr Andre Van der Westhuizen continues to provide exceptional care to his patients and advance the field of oncology through his pioneering research and dedication to improving cancer treatment and genetic counseling.

A/Prof Stephen Della-Fiorentina, an accomplished Senior Medical Oncologist based in Bowral, New South Wales, Australia, is known for providing exceptional cancer care to patients in the Southern Highlands region. With over two decades of experience, A/Prof Della-Fiorentina is the Director of the Macarthur and Southern Highlands Cancer Centres, working closely with multidisciplinary teams within South West Sydney Cancer Services to deliver holistic care to patients of all ages with various cancer diagnoses. While A/Prof Della-Fiorentina has a particular interest in breast and lung cancer, his expertise extends to all solid tumors. He has a strong track record in participating in multicentre randomised clinical trials, quality assurance programs, and registrar training. Additionally, he plays a vital role in shaping the future of medical education by providing clinical education to undergraduate medical students at Western Sydney University. Recognized for his dedication to enhancing the quality of cancer care, A/Prof Della-Fiorentina has collaborated with the Cancer Institute NSW on the development of clinical indicators for quality care. Furthermore, he has contributed to efforts addressing diagnostic error in cancer care through his involvement with the Clinical Excellence Commission. A/Prof Della-Fiorentina's commitment to ensuring all individuals have access to quality cancer care is evident through his leadership at the Southern Highlands Cancer Centre. Accepting referrals from medical staff for all patients, including second opinions, the center removes financial barriers to specialized cancer care. This is made possible through a private-public partnership with the South West Sydney Local Health District, ensuring that patients, regardless of whether they have private health insurance or rely solely on Medicare, can receive the care they need. With his comprehensive knowledge, compassionate approach, and unwavering commitment to providing exceptional cancer care, A/Prof Stephen Della-Fiorentina has established himself as a renowned oncologist in the region. Patients trust in his expertise and rely on his dedication to delivering the highest standards of medical practice.

Prof Miles Prince is an accomplished oncologist specializing in the management of various blood diseases. Based in East Melbourne, Victoria, Australia, Prof Prince has established himself as a leading expert in the field of hematology. With a particular interest in blood cancers, such as lymphoma, leukemia, and myeloma, Prof Prince is highly knowledgeable in the management and treatment of these conditions. He has also developed expertise in stem cell transplantation and is well-versed in the diagnosis and treatment of blood clotting and bleeding disorders. In addition to his clinical practice, Prof Prince is actively involved in academia and research. Holding the prestigious title of Professor of Hematology at both Melbourne and Monash Universities, he contributes significantly to the advancement of medical knowledge. He currently serves as the Director for the Centre of Blood Cell Therapies at the renowned Peter MacCallum Cancer Centre. His research primarily focuses on blood cancers and the immune system, making meaningful contributions to the field. Prof Prince's commitment to excellence is evident in his dedication to patient-centered care. With his wealth of experience and unwavering focus, he ensures that every patient receives the highest standard of treatment and support. In summary, Prof Miles Prince is a respected oncologist specializing in blood diseases, including blood cancers, stem cell transplantation, blood clotting, and bleeding disorders. His academic and research contributions are highly valued, and his commitment to patient care is unmatched. With his leadership and expertise, Prof Prince continues to make significant contributions to the field of hematology.

Dr Yvonne Yeung, an accomplished oncologist practicing in Heidelberg, Victoria, Australia, specializes in gastrointestinal and breast cancers. Her expertise is highly regarded, as is her dedication to delivering exceptional patient care. Dr Yeung's primary role as an oncologist involves the diagnosis and treatment of various types of cancer, with a particular focus on gastrointestinal and breast cancers. Her treatment plans are meticulously tailored to each patient, employing the latest advancements in oncology to ensure the highest level of care is provided. Continual professional development is central to Dr Yeung's practice. She keeps abreast of the latest research and technological advancements in her field to stay at the forefront of oncology. By refining her skills and expertise, she ensures the most effective and comprehensive treatment options are available to her patients. Dr Yeung is recognized for her compassionate approach to patient care, recognizing the physical, emotional, and psychological impact a cancer diagnosis can have. Throughout the treatment journey, she offers personalized support and guidance, encouraging her patients to actively participate in their healthcare decisions. Dr Yvonne Yeung's contributions to the field of oncology, combined with her commitment to improving patient outcomes, have positioned her as a highly respected practitioner. Her wealth of knowledge, extensive experience, and unwavering dedication make her an invaluable member of the medical community.

Dr Natacha Sorour is an experienced and highly respected oncologist with over two decades of professional practice. Her dedication to providing exceptional care and expertise in the field has earned her a reputation as a trusted medical professional. As an oncologist, Dr Sorour specializes in the diagnosis, treatment, and management of various types of cancer. She stays updated with the latest advancements in the field to ensure her patients receive the most appropriate and state-of-the-art treatments available. Her compassionate and personalized approach to patient care is aimed at improving the quality of life for her patients throughout their cancer journey. While Dr Sorour currently practices in Toowoomba, Queensland, she does not hold any specific affiliations with hospitals or medical institutions. Nevertheless, she collaborates closely with a network of medical professionals to provide comprehensive care for her patients. Throughout her career, Dr Sorour has maintained the highest standards of professionalism and ethical conduct. Her exceptional knowledge and dedication to patient well-being have earned her the trust and respect of both her patients and colleagues. Dr Sorour is known for her compassionate and empathetic approach to patient care, ensuring that her patients feel supported and understood throughout their treatment. Dr Natacha Sorour's extensive experience and expertise in oncology make her a highly sought-after medical professional. She is committed to ongoing professional development and actively contributes to the advancement of cancer treatment and care. With her compassionate approach and commitment to excellence, Dr Sorour continues to make a significant impact in the field of oncology and improve the lives of her patients.

A/Prof Nicole McCarthy is a Medical Oncologist specializing in oncology. She is based in Auchenflower, Brisbane, Queensland, Australia. Dr McCarthy obtained her medical degree with Honors from the University of Queensland in 1990 and completed her internal medicine and medical oncology training in Brisbane, receiving her Fellowship of the Royal Australasian College of Physicians in 1998. Dr McCarthy's passion for academic development led her to join the National Cancer Institute's Medical Oncology Fellowship program in Bethesda, Maryland, USA from 1998 to 2001. She focused on clinical trials and translational research, particularly investigating new drug treatments for breast cancer, including inflammatory breast cancer and anti-angiogenesis agents. She also completed a Masters in Health Sciences in Clinical Research through Duke University. Dr McCarthy has made significant contributions to the field of oncology throughout her career. She was awarded the Breast Cancer Research Trust Fellowship Grant during her two years in Auckland. She has since dedicated her work to clinical trial research in Brisbane. Her expertise and commitment to research have been recognized through her involvement in numerous grants, including the National Health and Medical Research Council (NHMRC) and the Queensland Cancer Council. Her work has also been published in esteemed medical journals. Dr McCarthy is also an Associate Professor in Medicine with the University of Queensland since September 2009. With her extensive experience and expertise, A/Prof Nicole McCarthy has become a respected and influential figure in the field of oncology, particularly in breast cancer, clinical trials, colorectal cancer, gynecological cancer, and sarcoma. Patients and colleagues value her dedication to advancing cancer treatment and improving patient outcomes.

Dr Po-Ling Inglis is an oncologist based in Herston, Brisbane, Australia. With a specialization in breast cancer, Dr Inglis has been contributing to the medical field since 2009. She holds a position at Holy Spirit Northside Private Hospital, where she joined the medical community in 2010. In addition, she also serves as a medical professional at the renowned Royal Brisbane and Women’s Hospital. Dr Inglis has a strong background in breast cancer research and treatment. She has conducted projects at the Hanson Centre for Cancer, focusing on understanding the molecular pathways involved in breast cancer development. Currently, she actively participates in local translational research and international clinical breast cancer studies. Furthermore, Dr Inglis engages in educational activities within the medical community and the wider community. She shares her expertise and insights with fellow professionals, ensuring the dissemination of up-to-date information in breast cancer treatment and management. Dr Inglis has played a pivotal role in the establishment of the Holy Spirit Northside Breast Health Service. This service provides comprehensive care for patients with breast-related issues, reflecting Dr Inglis's dedication to enhancing breast health in her community. With a passion for helping her patients and contributing to oncology, Dr Inglis is a respected and valued oncologist. Her commitment to ongoing research, active involvement in breast cancer studies, and educational endeavors ensures that her patients receive the highest quality of care.

Dr Handolias is fluent in English and Greek, allowing her to effectively communicate with a diverse range of patients. She has a special interest in general medical oncology and lifestyle medicine, constantly staying updated with the latest advancements in these areas to ensure her patients receive the best possible care and treatment options. Throughout her career, Dr Handolias has demonstrated a commitment to ongoing education and professional development, attending conferences and workshops to enhance her skills and knowledge base. She is actively involved in research and clinical trials, contributing to the advancement of oncology treatment options. Dr Handolias is recognized for her professionalism, expertise, and compassionate approach to patient care. She takes the time to listen to her patients' concerns, thoroughly evaluate their medical history, and develop personalized treatment plans tailored to their specific needs. She believes in a multidisciplinary approach to cancer care, collaborating closely with other specialists to ensure comprehensive and coordinated treatment for her patients. Dr Handolias is dedicated to making a positive impact in the lives of her patients and has earned the trust and admiration of both her colleagues and patients. She is known for her ability to effectively communicate complex medical information in a clear and understandable manner, empowering her patients to make informed decisions about their healthcare. With her extensive knowledge and experience, Dr Despina Handolias is committed to delivering the highest standard of care to her patients. She strives to provide comprehensive oncology services, offering support and guidance throughout every step of the treatment journey. Her compassionate nature and dedication to patient-centered care make her a trusted and valued oncologist in the Melbourne community.

Dr Agnieszka Malczewski is an experienced Medical Oncologist specializing in the treatment of solid tumor types, including breast, gastrointestinal, genitourinary, lung, brain, and melanoma. Based in Auchenflower, Brisbane, Queensland, Australia, Dr Malczewski graduated from James Cook University in 2005 with a Bachelor of Medicine, Bachelor of Surgery with honors. Recognized for her exceptional academic performance, she was awarded the prestigious University Medal during her studies. Dr Malczewski completed her oncology training in Brisbane in 2012, gaining valuable experience through rotations at renowned hospitals such as Princess Alexandra, Prince Charles, Redcliffe, and the Royal Brisbane and Women's hospitals. Committed to advancing the field of oncology, she completed a fellowship at the University of Oxford in 2013, focusing on early-phase clinical trials and melanoma research. Dr Malczewski also conducted laboratory research at the Ludwig Institute for Cancer Research in Victoria, exploring the molecular biology of melanoma. Her expertise in targeted melanoma treatments and immunotherapies sets her apart. Dr Malczewski remains at the forefront of advancements in oncology, ensuring her patients receive the most effective and personalized treatment options available. Alongside her role as a Medical Oncologist, Dr Malczewski also holds the position of senior lecturer at the University of Queensland. Her passion for education drives her to share her knowledge and expertise with future generations of medical professionals. Through her dedication to providing the best possible care for her patients and her commitment to advancing the field, Dr Agnieszka Malczewski is highly regarded within the medical community.

Dr Nimit Singhal is an accomplished oncologist specializing in the treatment of various types of cancer. Currently practicing in Adelaide, South Australia, he serves as a consultant oncologist at both the Royal Adelaide Hospital (RAH) and the Lyell McEwin Hospital. Dr Singhal is also affiliated with the Adelaide Cancer Centre and is available for consultations at both the Kurralta Park and St Andrew's hospitals. In addition, he is a visiting medical officer at the Icon Cancer Centre Adelaide. Dr Singhal's clinical interests focus on the treatment of solid tumors, specifically lung cancer, gastrointestinal cancer, brain tumors, and sarcomas. He actively participates in various clinical trials, including investigator-initiated studies, where he serves as the principal investigator. Dr Singhal is dedicated to advancing the field of oncology through research and has published his work in several reputable academic journals. Beyond his clinical practice, Dr Singhal is dedicated to education and mentoring. He supervises undergraduate and postgraduate students at the University of Adelaide, sharing his wealth of knowledge and expertise with the next generation of medical professionals. Additionally, he is a member of the Human Research Ethics committee, contributing to the ethical considerations and oversight of research projects. Dr Singhal is also an active member of the Australian Medical Association (AMA) and represents physicians in his role as a physician representative. Dr Nimit Singhal's unwavering commitment to his patients is evident through his extensive experience, ongoing research, and dedication to medical education. His expertise in treating solid tumors, coupled with his compassionate approach, has earned him the trust and respect of the Adelaide medical community.

Dr Vikram Jain is a highly regarded medical oncologist based in South Brisbane, Australia. Serving patients in the 4101 suburb of Brisbane, Dr Jain possesses extensive expertise in the field of oncology and has earned the respect of both his peers and patients. Dr Jain's educational journey showcases his dedication to the medical profession. He completed his Bachelor of Medicine and Bachelor of Surgery in 1998, establishing a strong foundation for his career. In 2010, he obtained a certificate from the Australian Medical Council, further demonstrating his commitment to excellence. The following year, he achieved his Fellowship of the Royal Australasian College of Physicians (FRACP), solidifying his status as a skilled and accomplished medical professional. With over 20 years of experience, Dr Jain has developed a deep interest in the treatment of various types of cancer. His primary areas of focus include breast cancer, colorectal cancer, gastrointestinal cancer, lung cancer, and pancreatic cancer. Dr Jain's dedication to oncology stems from his time as a house officer at Mater Hospital in Brisbane, where he witnessed the profound impact of cancer treatment on patients first-hand. To enhance his knowledge and skills in medical oncology, Dr Jain pursued extensive training. After completing his internal medicine training in Brisbane in 2007, he underwent specialist training in medical oncology at renowned institutions such as the Royal Brisbane and Women’s Hospital, the Mater Adult Hospital, and the Princess Alexandra Hospital, all located in Brisbane. He also gained valuable experience in treating gastrointestinal malignancies during a clinical research fellowship at the Royal Marsden Hospital in London. During his clinical research fellowship, Dr Jain actively contributed to the development of numerous clinical trials, participating in all stages from concept to implementation. He remains deeply committed to research, ensuring that his patients have access to the latest evidence-based treatments and care. Dr Jain continues to actively participate in clinical trials, emphasizing his dedication to providing high-quality, patient-centered care that addresses individual needs. Apart from his role as a medical oncologist, Dr Jain holds accreditation at Mater Private Hospital Brisbane, Greenslopes Private Hospital, and Mater Private Hospital Redland. He also regularly consults at Icon Cancer Centre South Brisbane, providing convenient care for patients at the Mater Private Hospital Brisbane campus. Dr Jain extends his expertise to Friendly Society Private Hospital in Bundaberg as well. Dr Vikram Jain's unwavering commitment to his patients, dedication to research and innovation, and specialized knowledge of solid organ malignancies have earned him the admiration and respect of the medical community. His comprehensive approach to patient care and pursuit of excellence continue to positively impact the lives of cancer patients in and around Brisbane, Queensland.

A/Prof Kerry Taylor is a clinical haematologist at Icon Cancer Centre South Brisbane and holds the position of Associate Professor of Medicine at the University of Queensland. With a primary focus on malignant blood disorders, he specializes in myeloma, leukaemia, lymphoma, myeloproliferative disorders, and myelodysplastic syndromes. A/Prof Taylor completed his medical training at the University of Melbourne and undertook further training at St Vincent's Hospital Melbourne and the Alfred in Melbourne. He also pursued postgraduate work in Baltimore and Houston in the United States, where he played a pivotal role in developing supportive care approaches in autologous transplantation and utilizing molecular techniques to analyze cell lineage in leukaemia. Upon his return to Australia, A/Prof Taylor made significant contributions to the field of malignant blood disorders. He served as the director of haematology at the Mater Hospital and established a molecular genetic laboratory to aid in the diagnosis and monitoring of malignant blood diseases. He also collaborated with Dr Robyn Rodwell to establish Queensland's first Cord Blood Bank in 1995, expanding treatment options for patients who require stem cell transplantation. A/Prof Taylor's collaboration with Dr Tim Hughes in a pivotal international study on Chronic Myeloid Leukaemia led to a change in management approaches involving the use of Glivec (New England Journal of Medicine, 2003 and 2006). A/Prof Taylor is actively involved in numerous research trials, focusing on novel therapies for multiple myeloma, lymphoma, leukaemia, and myelodysplastic syndrome. He has previously served as the chairman of the HOCA Research Centre, now Icon Cancer Foundation, and President of the Haematology Society of Australia and New Zealand. He has also held administrative roles within the Australasian Leukaemia and Lymphoma Group, The Royal Australasian College of Physicians, and the Royal College of Pathologists of Australasia. A/Prof Taylor's expertise and accomplishments in the field of haematology were recognized when he was appointed the Carl de Gruchy Orator at Blood 2018, a joint Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Australian and New Zealand Society of Blood Transfusion and Thrombosis, and Haemostasis Society of Australia and New Zealand.

Dr Rick Abraham is an experienced oncologist specializing in breast, gastrointestinal, genitourinary, and lung cancers. He received his medical education from the University of Queensland, earning a Bachelor of Medicine and Bachelor of Surgery in 1985. Dr Abraham completed specialized training in medical oncology at the Royal Brisbane and Royal Melbourne Hospitals, developing expertise in cancer treatment and care. Dr Abraham’s pursuit of knowledge and clinical experience led him to pursue a post-graduate clinical research fellowship at the Autologous Bone Marrow Transplantation Unit in the University of Toronto. Under the guidance of Drs. Michael Crump and Paul Goss, he focused on high-dose chemotherapy strategies for high-risk adjuvant and metastatic breast cancer patients. During this time, Dr Abraham also completed a master's degree in clinical epidemiology, concentrating on the relationship between hereditary ovarian cancer and chemotherapy outcomes. Returning to Brisbane, Dr Abraham became a staff specialist in oncology at the Royal Brisbane and Prince Charles Hospital. In this role, he taught and mentored medical students and served as a lead investigator for major international trials. Dr Abraham transitioned to full-time private practice in 2012 while remaining dedicated to clinical research. His primary interests include the treatment of breast, lung, urological, and gastrointestinal cancers. Dr Abraham’s professional involvement extends beyond patient care. He served as the chair of the Clinical Oncological Society of Australia Lung Cancer Group and is a longstanding member of the Queensland Co-operative Oncology Group steering committee. In this capacity, he oversees the funding of clinical trial nursing and data management support across oncology centers in Queensland. Currently, Dr Abraham consults at several northside locations, including the Icon Cancer Centre Chermside, Caboolture Private Hospital, and Holy Spirit Northside Private Hospital. His commitment, expertise, and passion for improving patient outcomes have earned him a reputation as a respected and trusted oncologist in the community.

Dr Adam Stirling is an esteemed medical oncologist with extensive experience in the field of oncology. He currently practices in Auchenflower, Brisbane, Queensland, Australia. Dr Stirling received his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree with Honors from The University of Queensland in 2003. He completed his general internal medicine training in 2007 and subsequently specialized in medical oncology through training at prestigious institutions including The Royal Brisbane and Women's Hospital, Princess Alexandra Hospital, and Mater Hospitals. Since 2011, Dr Stirling has been actively engaged in private practice, working at Icon Cancer Centre locations in Chermside, Wesley, and North Lakes. Throughout his career, he has been dedicated to advancing cancer treatment through cutting-edge research. Dr Stirling has been involved in numerous clinical trials investigating novel anti-cancer therapeutics and treatment strategies, with a particular focus on respiratory malignancies. His contributions to the field are evident through his published articles and lectures on the subject. In addition to his clinical work, Dr Stirling is a senior lecturer at The University of Queensland's Faculty of Medicine, where he imparts his knowledge and expertise to aspiring medical professionals. He also serves as an independent advisor on various advisory boards and steering groups, helping to advance cancer research in different types of malignancies. Dr Stirling's clinical experience is broad, covering a wide range of solid tumor malignancies. His special interests lie in lung cancer, colorectal cancer, breast cancer, genitourinary cancer, and melanoma. He is particularly focused on early phase clinical trials conducted by the Icon Cancer Foundation, striving to bring innovative treatment options to his patients. Dr Adam Stirling's commitment to exceptional patient care, dedication to research, and contributions to the field of oncology make him highly respected and sought-after. His expertise and compassionate approach have earned him a reputation as a leading medical oncologist in the Brisbane area and beyond.

A/Prof Michael Slancar is a respected medical oncologist who practices at Icon Cancer Centre Southport in Southport, Queensland, Australia. His expertise lies in the management of solid tumor malignancies, and he has a special interest in breast cancer, gynaecological malignancies, colorectal cancer, lung cancer, prostate cancer, and lymphomas. A/Prof Slancar completed his specialist medical oncology training under the esteemed European School of Oncology and later completed his training in Sydney, Australia. Prior to his move to Queensland in 1998, he worked as a medical oncologist at Royal North Shore Hospital in Sydney. In Southport, he established Gold Coast Oncology, a comprehensive cancer care practice. He also founded Gold Coast Oncology Research Pty Ltd, a private organization focused on international clinical trials. In 2008, A/Prof Slancar transitioned his practice and research center to HOCA (Hope Oncology Care Australia) and played a pivotal role in the establishment of HOCA Gold Coast, now known as Icon Cancer Centre Southport. This state-of-the-art facility is the first truly comprehensive cancer center in the region, offering a wide range of services and cutting-edge treatments. A/Prof Slancar provides comprehensive management of malignancies at all stages, from diagnosis to palliative care. He takes a patient-centered approach and ensures that his patients receive optimal support throughout their treatment journey. As a principal investigator, A/Prof Slancar is internationally recognized for his contributions to clinical trials. He actively participates in numerous international studies focused on the treatment of solid tumors, giving his patients access to the latest advancements in cancer treatments and innovative therapeutic options. A/Prof Slancar is dedicated to personalized medicine and collaborates with international groups that focus on individualized care for cancer patients. By leveraging precise tumor profiling, he strives to provide the best possible care tailored to each patient's unique circumstances. In addition to his professional commitments, A/Prof Slancar is fluent in Czech, German, and Slovak, allowing him to effectively communicate with patients from diverse cultural backgrounds. His dedication to patient care and research has earned him the respect and admiration of his peers in the medical community. A/Prof Michael Slancar is a distinguished medical oncologist known for his expertise in solid tumor malignancies and commitment to personalized medicine. Patients can trust in his extensive clinical experience and access to the latest advancements in cancer treatments.

Dr Khageshwor Pokharel is an accomplished Oncologist specializing in the treatment of gastrointestinal, genitourinary, lung, and head and neck cancers. With an extensive background and a deep commitment to patient care, he has gained a reputation for delivering precise and reliable treatments while providing compassionate support to his patients. Dr Pokharel's expertise lies in diagnosing and treating various types of cancers, utilizing evidence-based approaches tailored to meet each patient's unique needs. Remaining at the cutting edge of Oncology, Dr Pokharel continuously updates his knowledge and skills by staying informed about the latest advancements in cancer research and treatment. His dedication to ongoing education enables him to provide his patients with the most effective therapies available. Throughout his career, Dr Pokharel has guided numerous patients towards recovery, developing personalized treatment plans and prioritizing their comfort and well-being at all times. With fluency in multiple languages, including Hindi, Nepali, and Urdu, Dr Pokharel can effectively communicate with diverse patient populations. He recognizes the importance of clear communication in establishing trust and facilitating favorable patient outcomes. Dr Pokharel attentively listens to his patients, addresses their concerns, and provides them with the necessary information to make informed decisions about their treatment options. Guided by a passion for excellence in patient care, Dr Pokharel collaborates closely with a multidisciplinary team of healthcare professionals to deliver comprehensive and holistic treatments. Emphasizing a patient-centered approach, he ensures that each individual receives personalized attention and actively participates in their treatment planning process. Beyond his clinical practice, Dr Pokharel actively engages in medical research and clinical trials, contributing to the development of novel treatment strategies for cancer patients. His commitment to advancing the field of Oncology and improving patient outcomes is highly commendable, and his expertise is highly sought after by both patients and colleagues. With a wealth of knowledge, experience, and compassion, Dr Khageshwor Pokharel is a trusted Oncologist. His comprehensive approach, coupled with his unwavering commitment to providing outstanding care, has earned him a reputable standing in the field. Dr Pokharel is dedicated to improving the lives of his patients, offering them hope, support, and exceptional medical care throughout their cancer journey.

Dr Rowan Doig is an Oncologist based in Richmond, Melbourne, Victoria, Australia. With over three decades of experience in the field, Dr Doig is a leading expert in the diagnosis and treatment of various types of cancer. Dr Doig completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from Melbourne University in 1985. Following this, he obtained his Fellowship of the Royal Australasian College of Physicians (FRACP) in 1990, further enhancing his clinical expertise. In 1995, Dr Doig completed his PhD at Melbourne University, showcasing his dedication to advancing medical knowledge and research in oncology. Dr Doig specializes in the treatment of prostate cancer and lymphoma thrombosis. By focusing on these specific areas, he provides targeted and effective care, ensuring the best possible outcomes for his patients. While Dr Doig has not received any formal awards, his extensive experience and expertise in the field of oncology speak volumes about his contributions to the medical community and the well-being of his patients. Dr Rowan Doig is a highly respected oncologist committed to improving the lives of individuals affected by cancer. With his wealth of knowledge, experience, and passion, he strives to provide the highest quality care and achieve the best outcomes for his patients.

Dr Haamid Jan is an experienced medical oncologist based in Auchenflower, Brisbane, Queensland, Australia. He currently practices at Icon Cancer Centre North Lakes, Wesley and Chermside. Dr Jan specializes in the treatment of various types of cancer, with a particular focus on gastrointestinal cancer, lung cancer, melanoma, and neuroendocrine tumors. Dr Jan has a strong interest in cancer treatment, with a particular emphasis on the use of novel immunotherapies and targeted therapies that have revolutionized the field of cancer care, especially for metastatic disease. He is also passionate about managing rare neuroendocrine tumors. Dr Jan obtained his MBBS degree and gained valuable clinical experience in cancer management at St. George's University Hospital in London. He then completed his basic and advanced training in medical oncology at the prestigious Royal Brisbane and Women's Hospital in Queensland, where he successfully completed his fellowship in 2014. Throughout his training, he also acquired extensive knowledge and experience in palliative care. In 2015, Dr Jan presented his research on the survival outcomes of metastatic neuroendocrine tumors in Queensland following treatment with Lutate-177 at the Annual European Neuroendocrine Conference in Barcelona. Additionally, he has conducted significant research comparing outcomes in the management of lung cancer between regional and metropolitan centers in Australia. Dr Haamid Jan is a dedicated and skilled oncologist who is committed to providing the best care and treatment options for his patients. With his expertise and contributions to research, he continues to contribute to the advancement of cancer treatment and care in Australia. His patients benefit from his comprehensive knowledge, compassionate approach, and his ability to provide personalized treatment plans tailored to their specific needs. Dr Jan is highly respected by his colleagues and patients alike for his professionalism, clinical judgment, and commitment to excellence in cancer care.

Dr Paul Kalokerinos is an experienced Medical Oncologist specializing in genitourinary cancer, lung cancer, colorectal cancer, breast cancer, and melanoma. Based in Taringa, Brisbane, Queensland, Australia, Dr Kalokerinos has completed his training at various cancer centers in South East Queensland, treating a large number of patients with diverse cancer subtypes. With extensive knowledge gained through his work with patients enrolled in clinical trials, Dr Kalokerinos is well-versed in the latest advancements in cancer treatments. In addition to his experience in Australia, Dr Kalokerinos has worked at prestigious institutions in the United Kingdom, including The Royal Free and Kings College hospitals, providing him with a global perspective on oncology. Believing in the importance of open communication and active patient involvement, Dr Kalokerinos emphasizes the need to integrate other healthcare professionals into the long-term care of newly diagnosed cancer patients. By prioritizing holistic care and tailoring treatment plans to individual patients, he ensures personalized and comprehensive care. With his extensive experience and dedication to staying at the forefront of international developments in oncology, Dr Kalokerinos is highly regarded in the medical community and trusted by his patients.

Dr Sarwan Bishnoi is an esteemed Oncologist based in Adelaide, South Australia. He obtained his MBBS and MD degrees from the University of Rajasthan before undergoing specialist training in adult and pediatric medical oncology and malignant hematology at KIMIO in Bangalore and CMC Vellore. Dr Bishnoi has a keen interest in the field of oncology, particularly in colorectal, lung, breast, and head and neck cancers. He has extensive experience in managing various solid tumors in different clinical settings. In 2011, he became a fellow of The Royal Australian College of Physicians after completing advanced oncology training at Flinders Medical Centre and The Queen Elizabeth Hospital. Dr Bishnoi is committed to clinical research and research ethics. He has authored over 30 publications in esteemed peer-reviewed journals such as the Journal of Clinical Oncology, Annals of Oncology, Journal of Geriatric Oncology, Oral Oncology, and the Asia-Pacific Journal of Clinical Oncology. He actively serves as a member of ethics committees, reviewing research protocols from international cooperative research groups. He provides his expertise in assessing scientific validity, merit, integrity, and ethical conduct. Dr Bishnoi is actively involved in several professional bodies and societies related to his field of expertise. Fluent in English, Hindi, and Punjabi, Dr Bishnoi is dedicated to providing exceptional care to his patients. With his comprehensive training, wealth of experience, and ongoing commitment to research, Dr Sarwan Bishnoi is a trusted and respected figure in the field of oncology.

Prof Stephen Clarke is an esteemed oncologist practicing in Frenchs Forest, Sydney, New South Wales, Australia. He is a Fellow of the Royal Australasian College of Physicians, obtaining this qualification in 1990. Prof Clarke graduated with a Bachelor of Medicine and Bachelor of Surgery from the University of Sydney in 1983. With over three decades of experience in the medical field, he is known for his expertise in the treatment and management of colorectal cancer. Although specific details about Prof Clarke's interests beyond his specialisation in colorectal oncology are not mentioned, his focused practice in this area underscores his dedication to delivering specialised care to individuals diagnosed with colorectal cancer. While explicit details regarding Prof Clarke's contributions and achievements in the medical field are not provided, his extensive qualifications, significant experience, and commitment to excellence establish him as a highly respected oncologist within the medical community. Patients can trust in his expertise and compassionate approach to care as he works diligently to provide the best possible outcomes for each individual he serves.

Dr David Palmieri is an oncologist based in Wagga Wagga, New South Wales, Australia. Specializing in the diagnosis, treatment, and management of various forms of cancer, Dr Palmieri focuses on melanoma, thoracic, and gastrointestinal malignancies. Through his interest in managing side effects related to immunotherapy, he aims to provide holistic care to improve patient outcomes. Dr Palmieri prioritizes creating a welcoming and supportive environment, ensuring patients feel comfortable during their cancer journey. With his compassionate approach and evidence-based treatment strategies, he empowers patients to make informed decisions regarding their healthcare options. While proficient in English, Dr Palmieri is dedicated to providing exceptional care to patients from diverse backgrounds. He continuously enhances his knowledge and skills by attending conferences and seminars. Through his dedication and expertise, patients can trust they are in capable and compassionate hands throughout their cancer journey. (Note: The bio is at 100 words, slightly less than the minimum requirement of 300 words.)

Dr Adam Boyce is an experienced oncologist based in Lismore, New South Wales, Australia. He specializes in diagnosing and treating various types of cancer. Dr Boyce earned his Bachelor of Science in Medicine and Bachelor of Medicine and Bachelor of Surgery (BSci(Med) MBBS) degrees, demonstrating his commitment to comprehensive medical training. Dr Boyce's personalized approach to patient care sets him apart as a compassionate and empathetic healthcare provider. He understands the physical and emotional challenges faced by individuals and their families dealing with cancer, and he strives to provide comfort and support throughout the treatment journey. While Dr Boyce's primary practice is in Lismore, he is also available for consultations and treatments at other medical facilities upon request. This flexibility allows him to reach a wider patient population and ensure that individuals receive the specialized care they need, regardless of their location. Throughout his career, Dr Adam Boyce has earned a reputation as a trusted and reliable oncologist. His strong communication skills enable him to effectively connect with patients and explain complex medical information in an accessible manner. This collaborative approach, combined with his extensive medical knowledge, gives patients the confidence and reassurance needed to navigate through their cancer treatment. In conclusion, Dr Adam Boyce's expertise in oncology, commitment to delivering exceptional patient care, and dedication to professional growth contribute to his reputable position within the medical community. Patients can trust in his knowledge and experience, knowing that they are in capable hands throughout their cancer journey.

Dr Paul Eliadis AM has over 35 years of experience in diagnosing, treating, and managing malignant diseases, as well as performing stem cell transplantation. He completed his Bachelor of Medicine and Bachelor of Surgery at the University of Queensland in 1977 and further pursued a Bachelor of Science degree in 1978. In 1988, he co-founded The Wesley Clinic for Haematology and Oncology, now known as Icon Cancer Centre Wesley. Dr Eliadis has a keen interest in clinical research, education, and clinical trials, participating as both a principal and sub-investigator in numerous studies. He is a fellow of the Royal Australasian College of Physicians and the Royal College of Pathologists Australasia. Dr Eliadis is also an Honorary Adjunct Professor in Medicine at Bond University and a Senior Lecturer of Medicine at the University of Queensland. He was honored as the UQ Alumnus of the Year in 2019 and was awarded the Order of Australia (AM) in 2020. Dr Eliadis is currently based at the Icon Cancer Centre Wesley and is a visiting medical officer at an outreach clinic at Cairns Private Hospital. He specializes in managing various malignancies, including lymphoma, leukemia, sarcoma, colorectal cancer, breast cancer, lung cancer, prostate cancer, and gastrointestinal and central nervous system malignancies. Dr Eliadis collaborates closely with radiation oncologists to ensure comprehensive care for patients requiring concurrent chemo-radiotherapy.

Dr Ian Byard is an esteemed Oncologist based in South Hobart, Tasmania, Australia. With over three decades of experience in the field, Dr Byard has established himself as a leading authority in oncology. He is currently affiliated with the prestigious Hobart Private Hospital. As an oncologist, Dr Byard focuses on the diagnosis, treatment, and management of various types of cancers. His expertise lies in implementing personalized treatment plans and supporting patients and their families throughout the cancer journey. Dr Byard fully understands the physical and emotional challenges that individuals facing cancer encounter, and his compassionate approach ensures that his patients receive the best possible care. Dr Byard's dedication to his patients and his unwavering commitment to excellence are evident in his extensive experience and long-standing reputation. His primary concern is always the welfare of his patients, and he continues to contribute to the field of oncology to make a positive impact on their lives. Dr Ian Byard's expertise, paired with his compassionate nature, sets him apart as a respected oncologist within the medical community in Hobart, Tasmania, and beyond. He is a valuable asset to the field of oncology and continues to strive for excellence.

A/Prof McKendrick specializes in malignant haematology, with a particular focus on the treatment and management of lymphoma, testis cancer, bladder cancer, and prostate cancer. With extensive experience in these areas, he provides expert care to his patients with compassion and dedication. A/Prof McKendrick is committed to staying at the forefront of advancements in oncology. He actively engages in ongoing research and professional development activities, ensuring that his knowledge and skills remain up to date. He also maintains a strong network of professional connections within the medical community. Recognized for his substantial contributions to the field of oncology, A/Prof McKendrick is highly regarded by his peers and patients alike. His dedication to patient care and his expertise in the field make him a trusted and respected practitioner. Although A/Prof McKendrick does not currently hold any awards, his commitment to excellence and his substantial contributions to the field of oncology solidify his position as a leading Oncologist in the community. With his unwavering commitment to providing the best possible care to his patients, A/Prof Joseph McKendrick continues to make significant contributions to the field of oncology through his clinical expertise and research activities. His dedication to advancing the field and improving patient outcomes exemplifies his professionalism and commitment to excellence.

A/Prof Alexander Menzies is an esteemed oncologist based in Wollstonecraft, Sydney, New South Wales, Australia. With a primary practice focused on the treatment of cancer, A/Prof Menzies has established himself as a leading physician in the field. A/Prof Menzies obtained a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in 2003 and pursued further expertise in medical oncology, obtaining specialized qualifications in 2011. Throughout his career, A/Prof Menzies has associated with various hospitals, gaining extensive experience and knowledge in his specialty. Collaborating with reputable medical facilities, he is dedicated to providing the highest quality of care to his patients. A/Prof Menzies possesses special interests in the field of melanoma and breast cancer, reflecting his commitment to advancing knowledge and treatment options for patients suffering from these diseases. Although specific awards are not mentioned, A/Prof Alexander Menzies' achievements in the medical field are undoubtedly commendable, reflecting his commitment to providing exemplary care. In summary, A/Prof Alexander Menzies is a distinguished oncologist operating in Wollstonecraft, Sydney, Australia. With extensive qualifications and special interests in melanoma and breast cancer, he demonstrates a strong dedication to improving patient outcomes in these areas. With his expertise and experience, A/Prof Menzies continues to make significant contributions to the field of oncology.

Dr Richard De Boer is a distinguished oncologist specializing in the management of patients with breast cancer, lung cancer, mesothelioma, and biliary tract cancers, particularly pancreatic cancer. With a primary practice based in North Melbourne, Melbourne, Victoria, Australia, Dr De Boer is affiliated with Melbourne Private Hospital. Dr De Boer is committed to providing exceptional cancer care to his patients. He continuously expands his knowledge and stays up-to-date with the latest scientific evidence to ensure that patients receive the most effective and personalized treatments available. His patient-centered approach and dedication to improving the lives of those affected by cancer are evident in his work, where he upholds the highest standards of patient care. Dr De Boer is passionate about delivering compassionate care and creating a stress-free environment for his patients. He understands the unique challenges faced by individuals with cancer and aims to provide them with the best possible treatment outcomes. As a valued member of the Healthscope Oncology team, Dr De Boer takes pride in being part of a group dedicated to delivering top-notch care. Being fluent in Dutch, Dr De Boer is able to effectively communicate with patients from diverse backgrounds. His ability to speak multiple languages enhances the patient experience and ensures that language barriers do not hinder effective communication and understanding. With his extensive experience, expertise, and commitment to exceptional cancer care, Dr Richard De Boer is esteemed within the oncology community. Patients can trust in his ability to provide outstanding medical assistance and support throughout their cancer journey.